Correlation Between Vaxcyte and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Novo Nordisk AS, you can compare the effects of market volatilities on Vaxcyte and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Novo Nordisk.
Diversification Opportunities for Vaxcyte and Novo Nordisk
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Vaxcyte and Novo is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Vaxcyte i.e., Vaxcyte and Novo Nordisk go up and down completely randomly.
Pair Corralation between Vaxcyte and Novo Nordisk
Given the investment horizon of 90 days Vaxcyte is expected to under-perform the Novo Nordisk. In addition to that, Vaxcyte is 1.05 times more volatile than Novo Nordisk AS. It trades about -0.41 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.13 per unit of volatility. If you would invest 11,315 in Novo Nordisk AS on August 27, 2024 and sell it today you would lose (815.00) from holding Novo Nordisk AS or give up 7.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaxcyte vs. Novo Nordisk AS
Performance |
| Timeline |
| Vaxcyte |
| Novo Nordisk AS |
Vaxcyte and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxcyte and Novo Nordisk
The main advantage of trading using opposite Vaxcyte and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Vaxcyte vs. Eliem Therapeutics | Vaxcyte vs. HCW Biologics | Vaxcyte vs. Scpharmaceuticals | Vaxcyte vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |